The document identifies miR-27a as a potential tumor suppressor microRNA that is downregulated in leukemia. Functional experiments show that overexpression of miR-27a in leukemia cell lines inhibits cell growth and increases apoptosis. miR-27a is predicted to target several pro-apoptotic and cell cycle genes, and in vitro experiments confirm it directly binds to the 3'UTR of YWHAQ, a gene involved in apoptosis signaling. Further studies are needed to validate the tumor suppressor role of miR-27a in vivo and explore its potential as a therapeutic target or drug for leukemia treatment.